Opportunities

Active Solicitations

Closed Solicitations

RPP Identifier Date ReleasedRequirement TopicDescriptionRequiring OfficeSubmission Due Date
26-04-NBR8/6/2026Sustainment of PPE Capacities – Nitrile Butadiene Rubber (NBR)ASPR IBMSC is seeking to support production capacity for nitrile butadiene rubber (NBR) in support of personal protective equipment (PPE), specifically nitrile gloves manufacturing.IBMSC9/8/2026
26-09-Gloves8/6/2026Expansion of Domestic Manufacturing Capacity for Nitrile GlovesASPR IBMSC is seeking to expand the domestic manufacturing capacity of nitrile gloves.IBMSC9/8/2026
26-12-VMI8/11/2026Request for Project Proposals: Vendor Managed Inventory (VMI) Capabilities for APIs Used in Medical Countermeasure FDF Drug ProductsASPR IBMSC is seeking Vendor Managed Inventory (VMI) capabilities for APIs used in medical countermeasure FDF drug products.IBMSC9/14/2026
TypeRelease DateRequirement TopicClosed Date
Request for Information6/29/2026

Request for Information: Repurposing Equipment for Drug Delivery (REDD)

7/23/2026
RPP-26-02-AM-LVP2/6/2026

Production of Drug Substances and Drug Products at Commercial Scale - Anti-Microbials and Large Volume Parenterals

3/16/2026
Market Research1/26/2026

Market Research: Stabilization Technologies for CBRN Medical Countermeasures

2/19/2026
RPP-26-10-VHF10/15/2025Domestic Capability Building Activity – Onshoring the Manufacturing of Viral Hemorrhagic Fever Vaccine Candidates12/11/2025
RPP-25-11-Smart Ab9/10/2025Antibody (Ab) Advanced Manufacturing Capability Improvement: Smart Technologies10/22/2025
Market Research8/6/2025Market Research Survey: Personal Protective Equipment Manufacturing8/26/2025
Market Research3/26/2025Market Research Survey for Adherent Cell Culture Manufacturing4/9/2025
Market Research11/07/2024Market Research Survey for Pichia Expression System Capabilities11/21/2024
RPP-24-05-N958/2/2024Sustainment of N95 Respirator Manufacturing Capacity8/22/2024
RPP-24-06-Pipette6/27/2024Industrial Base Expansion of injection molded pipette tips and centrifuge tubes for use in the vaccine manufacturing and pandemic response supply chain7/25/2024
RPP-24-07-mAbs6/24/2024Manufacturing Optimization for Filovirus Monoclonal Antibodies8/05/2024
Request for Information3/20/2024Request for Information regarding Manufacturing Optimization for Filovirus Human Monoclonal Antibodies4/20/2024
RPP-24-03-Sterilization3/01/2024Sterilization Capacity for Vaccines and Therapeutics3/28/2024
RPP-24-02-KSM-API2/21/2024Production of Drug Substances and Drug Products at Commercial Scale3/20/2024
RPP-24-01-SmallMol1/11/2024Production of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale2/01/2024